Colchicine as an adjunct to heparin for prophylaxis of venous thromboembolism in patients with COVID-19

Chia Siang Kow; Syed Shahzad Hasan

doi:10.1007/s00296-020-04753-8

Colchicine as an adjunct to heparin for prophylaxis of venous thromboembolism in patients with COVID-19

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	677-678
Number of pages	2
Journal	Rheumatology International
Volume	41
Issue number	3
Early online date	2 Jan 2021
DOIs	https://doi.org/10.1007/s00296-020-04753-8
Publication status	Published - 1 Mar 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00296-020-04753-8Licence: Unspecified

Cite this

@article{71ce5a0f4c4c43d19760390d512bdba0,

title = "Colchicine as an adjunct to heparin for prophylaxis of venous thromboembolism in patients with COVID-19",

keywords = "Colchicine, Heparin, venous thromboembolism, COVID-19, COVID-19/drug therapy, Humans, Anticoagulants/adverse effects, Venous Thromboembolism/prevention & control, SARS-CoV-2, Hydroxychloroquine, Heparin/adverse effects, Pharmaceutical Preparations, Methotrexate, Colchicine/adverse effects",

author = "Kow, {Chia Siang} and Hasan, {Syed Shahzad}",

year = "2021",

month = mar,

day = "1",

doi = "10.1007/s00296-020-04753-8",

language = "English",

volume = "41",

pages = "677--678",

journal = "Rheumatology International",

issn = "0172-8172",

publisher = "Springer Verlag",

number = "3",

}

TY - JOUR

T1 - Colchicine as an adjunct to heparin for prophylaxis of venous thromboembolism in patients with COVID-19

AU - Kow, Chia Siang

AU - Hasan, Syed Shahzad

PY - 2021/3/1

Y1 - 2021/3/1

KW - Colchicine

KW - Heparin

KW - venous thromboembolism

KW - COVID-19

KW - COVID-19/drug therapy

KW - Humans

KW - Anticoagulants/adverse effects

KW - Venous Thromboembolism/prevention & control

KW - SARS-CoV-2

KW - Hydroxychloroquine

KW - Heparin/adverse effects

KW - Pharmaceutical Preparations

KW - Methotrexate

KW - Colchicine/adverse effects

UR - http://www.scopus.com/inward/record.url?scp=85098695674&partnerID=8YFLogxK

U2 - 10.1007/s00296-020-04753-8

DO - 10.1007/s00296-020-04753-8

M3 - Letter

C2 - 33388902

VL - 41

SP - 677

EP - 678

JO - Rheumatology International

JF - Rheumatology International

SN - 0172-8172

IS - 3

ER -

Colchicine as an adjunct to heparin for prophylaxis of venous thromboembolism in patients with COVID-19

UN SDGs

Access to Document

Other files and links

Cite this